Specialty Therapeutic Care Receives Equity Investment from Enhanced Equity Fund

Specialty Therapeutic Care, a Houston, TX-based national specialty pharmacy, providing healthcare management, pharmacy and delivery services to patients primarily suffering from chronic bleeding disorders, such as hemophilia, has received an equity investment of undisclosed amount from Enhanced Equity Fund.
The company intends to use the capital to take advantage of increasing organic growth opportunities as well as fund strategic acquisitions.
Founded in 2006 by President Matt Angell, STC is a national specialty pharmacy, currently licensed in 19 States, and a distributor of various blood products and pharmaceuticals to treat a wide array of bleeding disorders.
The transaction was led by Christopher J. Garcia and Kenton Rosenberry, both Partners at EEF.

Join the discussion